Role of Biotechnology in Drug Development explores the integration of biotechnological advancements in creating novel therapeutics. It covers techniques such as recombinant DNA technology, monoclonal antibodies, and gene therapy in drug development. The book emphasizes the potential of biotechnology to produce highly specific and effective treatments for various diseases. Ideal for biotechnologists and pharmaceutical scientists, it advances the synergy between biotech and pharma in developing cutting-edge drugs.
Samuel Spencer is a Biopharmaceutical Scientist with over 15 years of experience in drug discovery and development. He has published 90 peer-reviewed articles and coedited 3 books on biotechnology. Samuel’s research focuses on recombinant protein production, gene therapy, and biologic drug design. He has been a keynote speaker at international conferences on biotech innovations in pharmaceuticals.